Overexpression of checkpoint proteins have previously been linked to Lynch syndrome and abrogation of the checkpoint machinery has been shown to sensitize MMR deficient tumor cells towards chemotherapy [39], [40]. Here, MRC1 is linked to Lynch syndrome.